2014
DOI: 10.1016/j.jdiacomp.2013.10.004
|View full text |Cite
|
Sign up to set email alerts
|

Can hemoglobin A1c in early pregnancy predict adverse pregnancy outcomes in diabetic patients?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
23
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(23 citation statements)
references
References 20 publications
0
23
0
Order By: Relevance
“…The association between glycaemic control and other neonatal morbidity is less evident. A retrospective study of women with pre‐existing diabetes found no association between first trimester HbA 1c levels and adverse maternal or fetal outcomes 7 . More recently, a prospective trial of women with type 1 diabetes in the UK found that HbA 1c levels of 42–46 mmol/mol at 26 weeks' gestation were associated with LGA births, and HbA 1c levels of 48–52 mmol/mol were associated with pre‐term birth, pre‐eclampsia and a need for neonatal glucose infusion 19 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The association between glycaemic control and other neonatal morbidity is less evident. A retrospective study of women with pre‐existing diabetes found no association between first trimester HbA 1c levels and adverse maternal or fetal outcomes 7 . More recently, a prospective trial of women with type 1 diabetes in the UK found that HbA 1c levels of 42–46 mmol/mol at 26 weeks' gestation were associated with LGA births, and HbA 1c levels of 48–52 mmol/mol were associated with pre‐term birth, pre‐eclampsia and a need for neonatal glucose infusion 19 .…”
Section: Discussionmentioning
confidence: 99%
“…There are many gaps in the published literature about pregnancy outcomes for women with type 1 diabetes and their babies. Some studies have not distinguished the risks associated with type 1 and type 2 diabetes, 7 , 8 others have used less informative composite outcomes 7 9 or have not accounted for important confounders, such as maternal age, obesity and glycaemic control 5 , 10 . ‐ 12 The interaction between the effects of type 1 diabetes, glycaemic control and body mass index during pregnancy are not well understood, and there are no Australian data on this question.…”
mentioning
confidence: 99%
“…HbA1c is a recognised risk factor for congenital malformation and perinatal mortality, but the association with other pregnancy outcomes is less clear . A retrospective study of T2D in the US (2003–2011) found that early pregnancy HbA1c was not a good predictor of composite maternal or fetal outcomes . Conversely, third trimester HbA1c was a risk factor for LGA in a prospective cohort with pre‐existing diabetes in East Anglia (2006–2009) .…”
Section: Discussionmentioning
confidence: 99%
“…A population‐based study from the UK showed that strict glycemic control around the time of conception predicted appropriate fetal growth, whereas poor glycemic control in late gestation predicted fetal overgrowth . A smaller retrospective cohort study from 2014 of vaginal deliveries in women with diabetes suggested that every fourth woman with HbA1c ≥8.5% in early pregnancy experienced shoulder dystocia compared with 2% in women with HbA1c <8.5% . We observed higher HbA1c levels in early pregnancy in women with shoulder dystocia, but comparable glycemic control later in pregnancy.…”
Section: Discussionmentioning
confidence: 49%